Stocktoria
Senti Biosciences Holdings, Inc. SNTI
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2021-05-26
Senti Biosciences Holdings, Inc. statistics & valuation
Market cap$33.9M
P / B6.1×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Operating margin | -312631.8% | — | -3620.7% | -1448.5% | -1464.9% |
| Net margin | -279263.6% | — | -2774.6% | -1358.1% | -2003.6% |
| FCF margin | -198363.6% | — | -2515.9% | -1779.5% | -1455.2% |
| Return on assets | -119.9% | -54.0% | -59.5% | -32.2% | -57.2% |
| Return on equity | -1099.3% | -205.8% | -106.2% | -45.7% | 49.6% |
| Current ratio | 1.67 | 4.49 | 5.62 | 5.68 | 4.14 |
| Revenue growth | — | -100.0% | -40.2% | 55.2% | — |
Source: SEC EDGAR filings · CIK 0001854270 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.